You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2025

Details for Patent: 4,138,565


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,138,565
Title: Stable solutions and processes for their preparation
Abstract:Solutions of certain hydrogenated ergopeptide alkaloids in mixtures of pharmacologically acceptable alcohols and water have improved stability. Preferred solvents are mixtures of ethanol, propylene glycol and glycerol containing from 15-40% wt. of water and having dielectric constants between 34 and 46. With these solutions it is not essential to carry out the filing operation under an inert atmosphere.
Inventor(s): Ehrhardt; Lothar (Nuremberg, DE), Patt; Ludwig (Nuremberg, DE), Hartmann; Volker (Nuremberg, DE)
Assignee: Sandoz Ltd. (Basel, CH)
Application Number:05/833,784
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 4,138,565

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 4,138,565, exploring its background, claims, and the broader patent landscape.

Background of the Patent

United States Patent 4,138,565 was granted on February 6, 1979. To analyze this patent, one must first identify the invention it protects and the context in which it was filed.

Patent Search and Retrieval

To find detailed information about this patent, you can use the USPTO's Patent Public Search tool or visit the USPTO Public Search Facility. These resources provide access to prior art, patent documentation, and other relevant information[1].

Claims and Specifications

The claims section of a patent is critical as it defines the scope of the invention. Here are some key points to consider:

Claim Structure

Patent claims must "particularly point out and distinctly claim the subject matter which the applicant regards as his invention"[5]. For U.S. Patent 4,138,565, the claims would be detailed in the patent specification, outlining what the inventor considers to be the novel and non-obvious aspects of the invention.

Novelty, Usefulness, and Nonobviousness

For a patent to be granted, the invention must meet the criteria of novelty, usefulness, and nonobviousness. The patent application process involves a thorough search of prior art to ensure these criteria are met[4].

Patent Scope and Interpretation

The scope of a patent is determined by its claims, read in light of the specification and the prosecution history. Here’s how to interpret the scope:

Claim Language

The language used in the claims is precise and must inform those skilled in the art about the scope of the invention with reasonable certainty. Indefiniteness in claims can lead to their invalidation[5].

Specification and Drawings

The specification and any accompanying drawings provide context to the claims. They help in understanding the invention and its limitations. For example, drawings are often necessary to illustrate the invention and must meet the formal requirements set by the USPTO[4].

Patent Landscape

Understanding the broader patent landscape is essential for assessing the significance and potential impact of U.S. Patent 4,138,565.

Related Patents and Prior Art

Using tools like the Common Citation Document (CCD) or the Global Dossier, you can identify related patents and prior art cited by various patent offices. This helps in visualizing the patent family and understanding how the invention fits into the existing technological landscape[1].

Industry Impact

The impact of the patent on its industry can be gauged by looking at subsequent patents that build upon or cite this invention. The Patent Claims Research Dataset provided by the USPTO can offer insights into claim-level statistics and document-level statistics, which can help in understanding the patent's influence[3].

Legal and Practical Considerations

Infringement and Validity

Patent holders must be aware of potential infringement and validity challenges. Cases like Maxell, Ltd. v. Amperex Technology Limited highlight the importance of clear and distinct claims to avoid indefiniteness issues[5].

Maintenance and Enforcement

Maintaining a patent involves paying maintenance fees, and enforcing it requires monitoring for infringement. The USPTO provides resources such as the Patent Assignment Search to track changes in ownership and ensure the patent remains enforceable[1].

Key Takeaways

  • Claims Analysis: The claims section is pivotal in defining the scope of the invention.
  • Patent Search: Utilize USPTO tools to retrieve and analyze patent documentation.
  • Novelty, Usefulness, Nonobviousness: Ensure the invention meets these criteria to be patentable.
  • Patent Landscape: Understand related patents and prior art to assess the invention's impact.
  • Legal Considerations: Maintain clear and distinct claims to avoid legal challenges.

FAQs

Q: How do I find detailed information about U.S. Patent 4,138,565? A: You can use the USPTO's Patent Public Search tool or visit the USPTO Public Search Facility to access the patent documentation.

Q: What are the key criteria for patentability? A: The invention must be novel, useful, and non-obvious.

Q: How important are patent claims in defining the scope of an invention? A: Patent claims are crucial as they define what the inventor considers to be the novel and non-obvious aspects of the invention.

Q: What tools can I use to identify related patents and prior art? A: Tools like the Common Citation Document (CCD) and the Global Dossier can help in identifying related patents and prior art.

Q: Why is it important to maintain clear and distinct claims in a patent? A: Clear and distinct claims are essential to avoid indefiniteness issues and ensure the patent remains valid and enforceable.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. SBIR - THE U.S. PATENT APPLICATION PROCESS: https://www.sbir.gov/sites/all/themes/sbir/dawnbreaker/img/documents/Course16-Tutorial1.pdf
  5. CAFC - MAXELL, LTD. v. AMPEREX TECHNOLOGY LIMITED: https://cafc.uscourts.gov/opinions-orders/23-1194.OPINION.3-6-2024_2281183.pdf

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 4,138,565

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 4,138,565

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany2524184May 31, 1975
Germany2735587Aug 6, 1977

International Family Members for US Patent 4,138,565

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 1442276 ⤷  Try for Free
Australia 3867678 ⤷  Try for Free
Australia 508625 ⤷  Try for Free
Austria 355725 ⤷  Try for Free
Austria 364463 ⤷  Try for Free
Austria A390476 ⤷  Try for Free
Austria A567378 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.